| List of Plates |
|
xiii | |
| About the Editors |
|
xix | |
| List of Contributors |
|
xxi | |
| Foreword |
|
xxv | |
| Preface |
|
xxvii | |
| Book Summary |
|
xxxi | |
| Part I Enabling Magnetic Resonance Techniques for Tissue Engineering Applications |
|
1 | (148) |
|
1 Stem Cell Tissue Engineering and Regenerative Medicine: Role of Imaging |
|
|
3 | (18) |
|
|
|
|
|
|
|
|
|
|
|
3 | (2) |
|
|
|
5 | (3) |
|
1.3 Assessment of Stem Cell Differentiation and Tissue Development |
|
|
8 | (1) |
|
1.4 Description of Imaging Modalities for Tissue Engineering |
|
|
8 | (7) |
|
|
|
9 | (1) |
|
1.4.2 Fluorescence Microscopy |
|
|
9 | (2) |
|
1.4.3 Multiphoton Microscopy |
|
|
11 | (3) |
|
1.4.4 Magnetic Resonance Imaging |
|
|
14 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (6) |
|
2 Principles and Applications of Quantitative Parametric MRI in Tissue Engineering |
|
|
21 | (28) |
|
|
|
|
|
21 | (4) |
|
|
|
25 | (7) |
|
|
|
25 | (3) |
|
2.2.2 Radio Frequency Pulse Excitation and Relaxation |
|
|
28 | (3) |
|
|
|
31 | (1) |
|
2.3 MRI Contrasts for Tissue Engineering Applications |
|
|
32 | (6) |
|
|
|
33 | (1) |
|
2.3.2 Relaxation Times-T1 and T2 |
|
|
33 | (3) |
|
2.3.3 Water Apparent Diffusion Coefficient |
|
|
36 | (1) |
|
2.3.4 Fractional Anisotropy |
|
|
37 | (1) |
|
2.4 X-Nuclei MRI for Tissue Engineering Applications |
|
|
38 | (1) |
|
2.5 Preparing Engineered Tissues for MRI Assessment |
|
|
38 | (1) |
|
2.5.1 In Vitro Assessment |
|
|
38 | (1) |
|
|
|
39 | (1) |
|
2.6 Limitations of MRI Assessment in Tissue Engineering |
|
|
39 | (1) |
|
|
|
40 | (1) |
|
2.7.1 Biomolecular Nuclear Magnetic Resonance |
|
|
40 | (1) |
|
2.7.2 Cell-ECM-Biomaterial Interaction |
|
|
40 | (1) |
|
|
|
40 | (1) |
|
2.7.4 Standardization of MRI Methods for In Vitro and In Vivo Assessment |
|
|
40 | (1) |
|
2.7.5 Super-Resolution MRI Techniques |
|
|
41 | (1) |
|
2.7.6 Magnetic Resonance Elastography |
|
|
41 | (1) |
|
|
|
41 | (1) |
|
|
|
41 | (1) |
|
|
|
42 | (7) |
|
3 High Field Sodium MRS/MRI: Application to Cartilage Tissue Engineering |
|
|
49 | (22) |
|
|
|
|
|
49 | (1) |
|
3.2 Sodium as an MR Probe |
|
|
50 | (3) |
|
|
|
53 | (2) |
|
3.3.1 Pulse Sequences for Measuring TSC |
|
|
53 | (1) |
|
3.3.2 TQC Pulse Sequences for Measuring omegaQ and omega0tauc |
|
|
54 | (1) |
|
3.4 Assessment of Tissue-Engineered Cartilage |
|
|
55 | (8) |
|
3.4.1 Proteoglycan Assessment |
|
|
57 | (3) |
|
3.4.2 Assessment of Tissue Anisotropy and Molecular Dynamics |
|
|
60 | (1) |
|
3.4.3 Assessment of Osteochondral Tissue Engineering |
|
|
61 | (2) |
|
3.5 Sodium Biomarkers for Engineered Tissue Assessment |
|
|
63 | (1) |
|
3.5.1 Engineered Tissue Sodium Concentration (ETSC) |
|
|
63 | (1) |
|
3.5.2 Average Quadrupolar Coupling (omegaQ) |
|
|
64 | (1) |
|
3.5.3 Motional Averaging Parameter (omega0tauc) |
|
|
64 | (1) |
|
|
|
64 | (1) |
|
|
|
64 | (1) |
|
|
|
65 | (6) |
|
4 SPIO-Labeled Cellular MRI in Tissue Engineering: A Case Study in Growing Valvular Tissues |
|
|
71 | (20) |
|
|
|
|
|
4.1 Setting the Stage: A Clinical Problem Requiring a Tissue Engineering Solution |
|
|
71 | (1) |
|
4.2 SPIO Labeling of Cells |
|
|
72 | (4) |
|
|
|
72 | (1) |
|
4.2.2 Transfection Agents |
|
|
73 | (2) |
|
|
|
75 | (1) |
|
|
|
76 | (1) |
|
4.3.1 Traditional Usage of SPIO-Labeled Cellular MRI |
|
|
76 | (1) |
|
4.3.2 SPIO-Labeled Cellular MRI in Tissue Engineering |
|
|
76 | (1) |
|
4.4 Case Study: SPIO-Labeled Cellular MRI for Heart Valve Tissue Engineering |
|
|
77 | (6) |
|
4.4.1 Experimental Design |
|
|
77 | (1) |
|
4.4.2 Potential Approaches-In Vitro |
|
|
78 | (3) |
|
4.4.3 Potential Approaches-In Vivo |
|
|
81 | (2) |
|
4.5 Conclusions and Future Outlook |
|
|
83 | (1) |
|
|
|
84 | (1) |
|
|
|
84 | (7) |
|
5 Magnetic Resonance Elastography Applications in Tissue Engineering |
|
|
91 | (26) |
|
|
|
|
|
|
|
91 | (2) |
|
|
|
93 | (15) |
|
5.2.1 Theoretical Basis of MRE |
|
|
94 | (2) |
|
5.2.2 The Inverse Problem and Direct Algebraic Inversion |
|
|
96 | (5) |
|
5.2.3 Direct Algebraic Inversion Algorithm |
|
|
101 | (7) |
|
5.3 Current Applications of MRE in Tissue Engineering and Regenerative Medicine |
|
|
108 | (6) |
|
|
|
108 | (2) |
|
|
|
110 | (4) |
|
|
|
114 | (1) |
|
|
|
114 | (3) |
|
6 Finite-Element Method in MR Elastography: Application in Tissue Engineering |
|
|
117 | (12) |
|
|
|
|
|
|
|
117 | (1) |
|
6.2 FEA in MRE Inversion Algorithm Verification |
|
|
118 | (2) |
|
6.3 FEM in Stiffness Estimation from MRE Data |
|
|
120 | (1) |
|
6.4 FEA in Experimental Validation in Tissue Engineering Application |
|
|
121 | (3) |
|
6.5 Conclusions and Discussion |
|
|
124 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (4) |
|
7 In Vivo EPR Oxygen Imaging: A Case for Tissue Engineering |
|
|
129 | (20) |
|
|
|
|
|
|
|
|
|
129 | (2) |
|
|
|
131 | (1) |
|
7.3 Principles of EPR Imaging |
|
|
132 | (2) |
|
|
|
134 | (1) |
|
7.5 EPROI Instrumentation and Methodology |
|
|
135 | (3) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
136 | (1) |
|
|
|
137 | (1) |
|
7.6 Spin Probes for Pulse EPR Oxymetry |
|
|
138 | (1) |
|
|
|
139 | (1) |
|
7.8 Tissue Engineering Applications |
|
|
140 | (2) |
|
7.8.1 EPROI in Scaffold Design |
|
|
140 | (2) |
|
7.8.2 EPROI in Tissue Engineering |
|
|
142 | (1) |
|
7.9 Summary and Future Outlook |
|
|
142 | (1) |
|
|
|
142 | (1) |
|
|
|
143 | (6) |
| Part II Tissue-Specific Applications of Magnetic Resonance Imaging in Tissue Engineering |
|
149 | (234) |
|
8 Tissue-Engineered Grafts for Bone and Meniscus Regeneration and Their Assessment Using MRI |
|
|
151 | (28) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.1 Overview of Tissue Engineering with MRI |
|
|
151 | (1) |
|
8.2 Assessment of Bone Regeneration by Tissue Engineering with MRI |
|
|
152 | (5) |
|
8.3 MRI for 3D Modeling and 3D Print Manufacturing in Tissue Engineering |
|
|
157 | (4) |
|
8.4 Assessment of Menisci Repair and Regeneration by Tissue Engineering with MRI |
|
|
161 | (7) |
|
|
|
168 | (1) |
|
|
|
168 | (1) |
|
|
|
169 | (10) |
|
9 MRI Assessment of Engineered Cartilage Tissue Growth |
|
|
179 | (30) |
|
|
|
|
|
|
|
179 | (2) |
|
|
|
181 | (1) |
|
9.3 Cartilage Tissue Engineering |
|
|
182 | (2) |
|
|
|
183 | (1) |
|
|
|
183 | (1) |
|
|
|
183 | (1) |
|
|
|
183 | (1) |
|
|
|
184 | (1) |
|
|
|
184 | (1) |
|
9.4 Animal Models in Cartilage Tissue Engineering |
|
|
184 | (2) |
|
9.5 Tissue Growth Assessment |
|
|
186 | (1) |
|
9.6 MRI in the Assessment of Tissue-Engineered Cartilage |
|
|
187 | (1) |
|
9.7 Periodic Assessment of Tissue-Engineered Cartilage Using MRI |
|
|
187 | (12) |
|
9.7.1 Assessment of Tissue Growth In Vitro |
|
|
187 | (1) |
|
9.7.1.1 Accounting for Scaffold in Tissue Assessment |
|
|
191 | (1) |
|
9.7.2 Assessment of Tissue Growth In Vivo |
|
|
191 | (2) |
|
9.7.3 Assessment of Tissue Anisotropy and Dynamics |
|
|
193 | (1) |
|
9.7.3.1 Assessment of Macromolecule Composition |
|
|
194 | (1) |
|
9.7.3.2 Assessment of Tissue Anisotropy |
|
|
198 | (1) |
|
9.8 Summary and Future Directions |
|
|
199 | (1) |
|
|
|
200 | (9) |
|
10 Emerging Techniques for Tendon and Ligament MRI |
|
|
209 | (28) |
|
|
|
|
|
|
|
|
|
|
|
10.1 Tendon and Ligament Structure, Function, Injury, and Healing |
|
|
209 | (2) |
|
10.2 MRI Studies of Tendon and Ligament Healing |
|
|
211 | (8) |
|
10.3 MRI and Contrast Mechanisms |
|
|
219 | (9) |
|
10.3.1 Conventional MRI Techniques |
|
|
219 | (3) |
|
10.3.2 Advanced MR Techniques |
|
|
222 | (6) |
|
10.4 Significance and Conclusion |
|
|
228 | (1) |
|
|
|
228 | (1) |
|
|
|
228 | (9) |
|
11 MRI of Engineered Dental and Craniofacial Tissues |
|
|
237 | (14) |
|
|
|
|
|
|
|
237 | (1) |
|
|
|
238 | (1) |
|
11.3 Extracellular Matrix |
|
|
238 | (1) |
|
11.4 Tissue Regeneration of Dental-Craniofacial Complex |
|
|
239 | (4) |
|
11.4.1 Advantages of Using ECM Scaffolds with Stem Cells |
|
|
240 | (2) |
|
|
|
242 | (1) |
|
11.5 MRI in Tissue Engineering and Regeneration |
|
|
243 | (3) |
|
11.5.1 MRI of Human DPSCs |
|
|
243 | (1) |
|
11.5.2 MRI of Tissue-Engineered Osteogenic Scaffolds |
|
|
244 | (1) |
|
11.5.3 MRI of Chondrogenic Scaffolds with Cells In Vitro |
|
|
244 | (1) |
|
11.5.4 MRI of Chondrogenic Scaffolds with Cells In Vivo |
|
|
245 | (1) |
|
11.5.5 MRI Can Differentiate Between Engineered Bone and Engineered Cartilage |
|
|
246 | (1) |
|
11.5.6 MRI to Assess Angiogenesis |
|
|
246 | (1) |
|
11.6 Challenges and Future Directions for MRI in Tissue Engineering |
|
|
246 | (1) |
|
|
|
247 | (1) |
|
|
|
247 | (4) |
|
12 Osteochondral Tissue Engineering: Noninvasive Assessment of Tissue Regeneration |
|
|
251 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
251 | (1) |
|
12.2 Osteochondral Tissue Engineering |
|
|
252 | (5) |
|
12.2.1 Osteochondral Tissue |
|
|
252 | (1) |
|
12.2.2 Biomaterials/Scaffolds |
|
|
252 | (3) |
|
|
|
255 | (1) |
|
|
|
256 | (1) |
|
12.3 Clinical Methods for Osteochondral Defect Repair and Assessment |
|
|
257 | (5) |
|
12.3.1 Diagnostic Modalities |
|
|
257 | (3) |
|
|
|
260 | (1) |
|
|
|
260 | (1) |
|
12.3.2.2 Autografts and Allografts |
|
|
260 | (1) |
|
12.3.2.3 Tissue Engineering Grafts |
|
|
262 | (1) |
|
12.4 MRI Assessment of Tissue Engineered Osteochondral Grafts |
|
|
262 | (2) |
|
12.4.1 In Vitro Assessment |
|
|
263 | (1) |
|
12.4.2 In Vivo Assessment |
|
|
264 | (1) |
|
12.5 MRI Assessment Correlation with Histology |
|
|
264 | (1) |
|
12.6 Conclusions and Challenges |
|
|
265 | (1) |
|
|
|
265 | (1) |
|
|
|
265 | (8) |
|
13 Advanced Liver Tissue Engineering Approaches and Their Measure of Success Using NMR/MRI |
|
|
273 | (38) |
|
|
|
|
|
|
|
|
|
|
|
273 | (5) |
|
13.2 MRS and MRI Compatibilization-Building Compact RF MR Probes for BALs |
|
|
278 | (2) |
|
13.3 Multinuclear MRS of a Hybrid Hollow Fiber-Microcarrier BAL |
|
|
280 | (6) |
|
13.3.1 Viability by 31P MRS |
|
|
282 | (2) |
|
13.3.2 Quantifying Drug Metabolic Activity and Oxygen Distribution by 19F MRS |
|
|
284 | (2) |
|
13.4 1H MRI of a Hollow Fiber Multicoaxial BAL |
|
|
286 | (7) |
|
13.4.1 BAL Integrity and Quality Assurance |
|
|
286 | (2) |
|
13.4.2 Inoculation Efficiency and Prototype Redesign Iteration |
|
|
288 | (1) |
|
|
|
289 | (2) |
|
13.4.4 Diffusion-Weighted and Functional Annotation Screening Technology (FAST) Dynamic Contrast MRI |
|
|
291 | (2) |
|
13.5 Magnetic Contrast Agents Used in MRI of Liver Stem Cell Therapy |
|
|
293 | (1) |
|
13.6 31P and 13C MRS of a Fluidized-Bed BAL Containing Encapsulated Hepatocytes |
|
|
294 | (4) |
|
13.6.1 31P MRS Resolution, SNR, Viability, and pH |
|
|
296 | (1) |
|
13.6.2 13C MRS to Monitor Real-Time Metabolism |
|
|
296 | (2) |
|
|
|
298 | (3) |
|
13.7.1 Dynamic Nuclear Polarization |
|
|
298 | (2) |
|
13.7.2 Constructing Artificial Organs |
|
|
300 | (1) |
|
|
|
301 | (2) |
|
|
|
303 | (1) |
|
|
|
303 | (8) |
|
14 MRI of Vascularized Tissue-Engineered Organs |
|
|
311 | (22) |
|
|
|
|
|
311 | (1) |
|
14.2 Importance of Vascularization in Tissue Engineering |
|
|
312 | (2) |
|
14.3 Vessel Formation and Maturation: Implications for Imaging |
|
|
314 | (3) |
|
14.4 Imaging Approaches to Assess Vascularization |
|
|
317 | (1) |
|
14.5 Dynamic Contrast-Enhanced MRI for Imaging Vascular Physiology |
|
|
318 | (3) |
|
14.6 Complementary MRI Techniques to Study Vascularization |
|
|
321 | (4) |
|
14.7 Considerations for Preclinical Models and Translation to Clinical Implementation |
|
|
325 | (1) |
|
|
|
326 | (1) |
|
|
|
327 | (1) |
|
|
|
327 | (6) |
|
15 MRI Tools for Assessment of Cardiovascular Tissue Engineering |
|
|
333 | (34) |
|
|
|
|
|
|
|
15.1 The Heart and Heart Failure |
|
|
333 | (1) |
|
15.2 Cardiac Engineering and Cell Therapy |
|
|
334 | (2) |
|
15.3 Imaging Heart Failure |
|
|
336 | (10) |
|
|
|
336 | (2) |
|
15.3.2 Regional Heart Function |
|
|
338 | (2) |
|
|
|
340 | (2) |
|
15.3.4 Relaxometry and Parametric Imaging |
|
|
342 | (2) |
|
15.3.5 Myocardial Perfusion Imaging |
|
|
344 | (2) |
|
15.4 Imaging Cardiac Regeneration |
|
|
346 | (2) |
|
15.5 Monitoring Cardiac Regeneration |
|
|
348 | (7) |
|
15.5.1 MRI to Track Stem Cells |
|
|
348 | (5) |
|
15.5.2 MRI to Track Engineered Tissues |
|
|
353 | (2) |
|
15.6 Translational Potential and Future Directions |
|
|
355 | (2) |
|
|
|
357 | (10) |
|
16 Peripheral Nerve Tissue Engineering and Regeneration Observed Using MRI |
|
|
367 | (16) |
|
|
|
|
|
|
|
367 | (1) |
|
16.2 Receiver Coils Commonly Applied in Nerve Tissue Engineering |
|
|
368 | (1) |
|
16.3 Various Tools for Real-lime Monitoring of the Nerve Regeneration |
|
|
368 | (1) |
|
16.4 Current Materials, Methods, and Concepts in Peripheral Nerve Repair |
|
|
368 | (3) |
|
16.5 MRI Parameters in Peripheral Nerve Tissue Engineering |
|
|
371 | (2) |
|
16.6 Advantages of Real-Time Monitoring of Nerve Regeneration Using MRI |
|
|
373 | (1) |
|
16.7 Choosing Animal Models for MRI Studies of Peripheral Nerve Tissue Engineering |
|
|
374 | (1) |
|
16.8 Imaging Ability Through Nerve Conduits of Peripheral Nerve Tissue Engineering |
|
|
375 | (1) |
|
16.9 Further Imaging Functions of MRI in Peripheral Nerve Tissue Engineering |
|
|
376 | (1) |
|
16.10 Tractography in Peripheral Nerve Tissue Engineering |
|
|
376 | (2) |
|
16.11 Novel Contrast Agents |
|
|
378 | (1) |
|
|
|
378 | (1) |
|
|
|
379 | (4) |
| Index |
|
383 | |